GLI Pathogenesis-Related 1 (GLIPR1) (Center) Peptide
GLIPR1
Reactivité: Humain
Hôte: Synthetic
BP, BI
Sodium azide
-
- Antigène Tous les produits GLIPR1
- GLIPR1 (GLI Pathogenesis-Related 1 (GLIPR1))
- Protein Region
- Center
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- 18 amino acids near the center of human GLIPR1.
-
-
- Indications d'application
- The peptide is used for blocking the activity of GLIPR1 antibody . It usually blocks the antibody activity completely by incubating the peptide with equal volume of antibody for 30 min at 37˚,C.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Reconstitution
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Concentration
- 200 μg/mL
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store GLIPR1 peptide at -20°C, stable for one year.
- Date de péremption
- 12 months
-
- Antigène
- GLIPR1 (GLI Pathogenesis-Related 1 (GLIPR1))
- Synonymes
- CRISP7 Peptide, GLIPR Peptide, RTVP1 Peptide, 2410114O14Rik Peptide, RTVP-1 Peptide, mRTVP-1 Peptide, GLIPR1 Peptide, zgc:65887 Peptide, GLI pathogenesis related 1 Peptide, GLI pathogenesis-related 1 Peptide, GLI pathogenesis-related 1 (glioma) Peptide, GLI pathogenesis-related 1b Peptide, GLIPR1 Peptide, Glipr1 Peptide, glipr1b Peptide
- ID gène
- 11010
- NCBI Accession
- NP_006842
- OMIM
- 110825980
- UniProt
- P48060
-
Vous êtes ici:
